Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

Carvedilol-IPD-MA-group, From the PREDESCI study (Ref. 7)

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Neuroscience